Alvobak (ceftriaxone) powder for solution for injections 1g. №1 vial


Manufacturer: Spain



Treatment of the following infections in adults and children, including term infants (from birth):
bacterial meningitis;
community-acquired pneumonia;
hospital pneumonia;
acute otitis media;
intraperitoneal infections;
complicated urinary tract infections (including pyelonephritis);
infections of bones and joints;
complicated infections of the skin and soft tissues;
bacterial endocarditis.
Alvobak can be used for:
treatment of acute complication of chronic obstructive pulmonary disease in adults;
for the treatment of disseminated Lyme borreliosis (early (stage II) and late (stage i)) in adults and children, including infants aged 15 days;
preoperative prophylaxis of infections at the site of surgery;
for the management of patients with neutropenia who have developed a fever with suspected bacterial infection;
for the treatment of patients with bacteraemia that has arisen from any of the above infections, or if any of the above infections is suspected.
Alvobac should be administered with other antibacterial agents if the possible range of bacterial pathogens does not fall within its spectrum of activity (see section “Application Features”).
Official guidelines for the appropriate use of antibacterial agents should be considered.